
Posted on 9월 30, 20249/30/24
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy

Posted on 9월 7, 20239/7/23
Asset Optimization: Breathe New Life Into Mature Brands with EVERSANA REIGNITE™

Posted on 11월 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023

Posted on 10월 17, 202210/17/22
Developing Best-in-class Copay Programs for Gross-to-Net

Posted on 8월 4, 20228/4/22
Macroeconomic Factors Impact Cash Flow for Pharma

Posted on 4월 7, 20224/7/22
Reigniting Revenue for Established Brands

Posted on 4월 7, 20224/7/22
Reignite Established Brands — Actual Use Case

Posted on 4월 29, 20214/29/21
Visualizing EVERSANA’s Omnichannel Activation Model

Posted on 4월 13, 20214/13/21